Core Laboratories NV (NYSE: CLB) has reported earnings for its first fiscal quarter (ending March 31) of $0.07 versus $0.05 for the same period a year ago. E.P.S. were $0.80 for the latest four quarters through March 31 versus $0.50 for the same period a year ago.
Recent Price Action
On 4/24/24, Core Laboratories NV (NYSE: CLB) stock declined by -2.7%, closing at $16.53. This decline was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months and has declined -4.1% during the last week.
Current PriceTarget Research Rating
CLB is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Core Laboratories has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Core Laboratories has a very low Appreciation Score of 14 and a very low Power Rating of 12, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information and negative market action we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment